Skip to content
healthcare.dev

Cyklokapron

NDC 0013-1114, tranexamic acid, injection, solution, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
0013-1114
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA019281
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0013-1114 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRANEXAMIC ACID100 mg/mL

Pharmacologic classes

Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]

Package NDCNDC-11Package
0013-1114-15000131114151 AMPULE in 1 CARTON (0013-1114-15) / 10 mL in 1 AMPULE (0013-1114-01)
0013-1114-210001311142110 VIAL in 1 BOX (0013-1114-21) / 10 mL in 1 VIAL (0013-1114-20)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e89a7d9-4da4-42aa-b7f8-c602c24eefe5

Use it

Look up 0013-1114 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0013-1114 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0013-1114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.